Activation of human inactive ("pro-") renin by cathepsin D and pepsin

The Journal of Clinical Endocrinology and Metabolism
B J Morris

Abstract

Inactive human renin is found in amniotic fluid, plasma, and kidney and may be a renin precursor ("prorenin"). The mechanism of activation of inactive renin in vivo is not known. The present study examined the hypothesis that cathepsin D, a lysosomal pepsin-like endopeptidase may be capable of eliciting activation. Cathepsin D was incubated with inactive renin in human amniotic fluid at pH 4.8 and 22 C for 0-5 h. Marked activation occurred and the reaction displayed first order kinetics with respect to the concentration of cathepsin D. The initial velocity of conversion of inactive renin to active renin by cathepsin D was 0.007%/min/microgram cathepsin D. Under identical conditions, the initial velocity of conversion by pepsin was 0.18%/min/microgram pepsin. The 25-fold higher potency of pepsin compared with cathepsin D is in accordance with the recognized relative substrate affinities and catalytic efficiencies of the two enzymes. Inactive renin in human amniotic fluid seems to be similar to that found in human kidney and since cathepsin D is present in juxtaglomerular cells, this activation process may have physiological importance.

Citations

Jul 16, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·P J LijnenR H Fagard
May 21, 1979·Life Sciences·M L OverturfW M Kirkendall
Nov 28, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·A H M Nurun Nabi, Fumiaki Suzuki
Nov 1, 1979·Clinical and Experimental Pharmacology & Physiology·R P Day, B J Morris
Sep 1, 1980·Clinical and Experimental Pharmacology & Physiology·B J MorrisD F Catanzaro
Jan 1, 1987·Clinical and Experimental Pharmacology & Physiology·B J Morris, J E Taylor
Jan 1, 1990·Clinical and Experimental Hypertension. Part A, Theory and Practice·D B EvansS K Sharma
Jan 1, 1980·Clinical and Experimental Hypertension : CHE·F H DerkxM A Schalekamp
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·J A LuetscherG Grislis
Aug 1, 1981·Journal of the American Geriatrics Society·M NakamaruK Murakami
Aug 29, 1980·Biochemical and Biophysical Research Communications·R L Johnson, A M Poisner
Oct 23, 2003·Physiological Genomics·Faina SchwartzHaralambos Gavras
Mar 1, 1996·Hypertension·F A NevesJ D Baxter
Sep 1, 1984·Hypertension·Y DoiP J Mulrow
Oct 4, 2013·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Eugenie R Lumbers, Kirsty G Pringle
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·D F Catanzaro, B J Morris
May 17, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hirokuni TetsuoKatsusuke Yano
Feb 11, 2021·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kazumi FujimotoMasayoshi Shichiri
Jan 15, 1981·Biochimica Et Biophysica Acta·C H Lawrence, B J Morris
Nov 10, 1978·Biochimica Et Biophysica Acta·B J Morris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.